Digital Simulated clinical trial populations and AI scalability AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
Sales & Marketing HCP marketing’s Pharma 4.0 moment: Leveraging AI for real-ti... With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.
Digital Trust by design: Crafting authentic connections through digi... The pharmaceutical industry has long struggled to earn and sustain trust.
R&D Six life sciences real estate trends to watch in 2025 Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs.
Sales & Marketing Partner Content AI Literacy for Pharma Marketing Career Success Preparing for AI Success in 2025 and Beyond: Insights from Our 2024 Research.
Digital Reflecting on a decade at CES: Has digital health really tra... It’s been a decade since I first navigated the dazzling chaos of CES in Las Vegas. The buzz of innovation was thrilling, yet overwhelming.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.